Corrections
- PMID: 29263001
- DOI: 10.1016/S1474-4422(17)30427-1
Corrections
Erratum for
-
Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trial.Lancet Neurol. 2018 Jan;17(1):35-46. doi: 10.1016/S1474-4422(17)30378-2. Epub 2017 Nov 6. Lancet Neurol. 2018. PMID: 29122523 Clinical Trial.
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources